Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MUU vs GSK✓SelectedUSD · GSKMUU vs GSK performance historyLatest closeAs of-27.90%11/20
Stock and ETF performance explorer

MUU vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+670.0%
GSK return
+29.5%
Excess return
+640.5%
Maximum drawdown
-84.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-27.9%-0.1%-27.8%-27.9%
7D-43.9%-5.3%-38.6%-44.4%
30D-63.2%-3.7%-59.6%-63.4%
3M-69.8%-7.3%-62.5%-69.9%
6M-61.9%-4.2%-57.7%-62.2%
YTD+93.5%+0.9%+92.7%+87.2%
1Y+271.8%+7.3%+264.5%+250.1%
All+670.0%+29.5%+640.5%+532.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling